Ayana Takemura

Hamamatsu, 4313192, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Deep learning-based automated identification of papillary bladder cancer from endoscopic still images using SE-ResNeXt-50.

Deep learning-based automated identification of papillary bladder cancer from endoscopic still images using SE-ResNeXt-50.

Journal: World journal of urology

Published: May 17, 2026

Current Kidney-Preserving Strategies for Upper Tract Urothelial Carcinoma.

Current Kidney-Preserving Strategies for Upper Tract Urothelial Carcinoma.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: July 07, 2025

Comparing Perioperative Outcomes Using Single and Multiple Robot Systems During the Learning Period for Robot-Assisted Radical Prostatectomy.

Comparing Perioperative Outcomes Using Single and Multiple Robot Systems During the Learning Period for Robot-Assisted Radical Prostatectomy.

Journal: Asian journal of endoscopic surgery

Published: March 21, 2025

Comparing oncological outcomes and safety between photodynamic diagnosis-assisted and white-light transurethral resection in elderly patients with non-muscle invasive bladder cancer.

Comparing oncological outcomes and safety between photodynamic diagnosis-assisted and white-light transurethral resection in elderly patients with non-muscle invasive bladder cancer.

Journal: Japanese journal of clinical oncology

Published: December 27, 2024

Use of Preoperative Renal Volumetry to Predict Postdonation Renal Function With Inulin Clearance as Indicator in Japan.

Use of Preoperative Renal Volumetry to Predict Postdonation Renal Function With Inulin Clearance as Indicator in Japan.

Journal: Transplantation proceedings

Published: December 26, 2024

Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma.

Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma.

Journal: Anticancer research

Published: December 21, 2023

Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.

Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: September 05, 2022

Pembrolizumab Versus Combined Chemotherapy With Gemcitabine and Paclitaxel: A Comparative Assessment of Clinical Outcomes in Patients With Platinum-refractory Advanced Urothelial Cancer.

Pembrolizumab Versus Combined Chemotherapy With Gemcitabine and Paclitaxel: A Comparative Assessment of Clinical Outcomes in Patients With Platinum-refractory Advanced Urothelial Cancer.

Journal: In vivo (Athens, Greece)

Published: February 13, 2021

Decreased D2-40 immunoreactivity in stored paraffin sections and methods for preserving it.

Decreased D2-40 immunoreactivity in stored paraffin sections and methods for preserving it.

Journal: Biotechnic & histochemistry : official publication of the Biological Stain Commission

Published: June 19, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026